Hold AXP at 65-75% target weight pending Q3 credit-loss validation; reject new buying into bearish-coil resolution
Hold AXP at 65-75% of target weight; do not initiate new positions ahead of Q3 earnings. The staged buy at $332 with stop at $319 is structurally disciplined but contradicts the binding five-data-point pattern of failed AXP directional entries into this exact coiled setup. Full Sell forfeited due to durable structural premium (34% ROE, 16% EPS CAGR, Berkshire anchor, widening moat). Overweight requires three confirmations: close above $354.47 with positive MACD histogram AND volume > 3M shares; or successful retest of $319-328 support with bullish reversal candle on above-average volume. Q3 earnings and the $354.47/$319 levels are the validation anchors.
| Position | Action |
|---|---|
| Default positioning per Aug 14 binding reflection | Maintain AXP at 65-75% of target weight |
| Close below $319 on volume | Full exit consideration; confirms credit-cycle inflection |
AXP is a best-in-class compounder trading at a technical discount, with the bearish technical breakdown actually representing a high-probability mean-reversion setup supported by accelerating earnings, NII momentum from higher-for-longer rates, and structural commercial card growth.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 341.24 | bearish |
| 50 SMA | 340.14 | bearish |
| 200 SMA | 337.64 | bearish |
| RSI(14) | 44.84 | neutral |
| MACD | -0.09 | bearish |
| MACD Signal | 0.48 | bearish |
| MACD Histogram | -0.57 | bearish |
| Bollinger Upper Band | 352.90 | neutral |
| Bollinger Middle Band (20 SMA) | 340.69 | neutral |
| Bollinger Lower Band | 328.48 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Successful retest of $319-328 support cluster producing bullish reversal candle on above-average volume
Then: Consider shifting to Overweight
The P/B multiple of 6.6x is justified and fair relative to ROE
↩ rebuts: “Bear's 'premium valuation' claim of 20x P/E and 6.6x P/B being 'overvalued'”
EV: +$370-$400 (12-18 month target) · concedes: MACD did turn negative from peak of +8.73 on July 16th (though described as healthy consolidation from overbought); PEG of 1.6 is 'slightly rich' (though argued as reasonable for 34% ROE compounder); Sentiment score 6.2/10 is 'Mildly Bullish' with low confidence; Berkshire 'didn't add AXP' (though Berkshire also didn't sell AXP and initiated Delta)
AXP's quality-at-any-price thesis is a trap; the technical breakdown below all major moving averages combined with credit cycle vulnerability ($225B in loans, 72% of assets), upper-end valuation (P/E 20x, P/B 6.6x), and Berkshire's de-prioritization signal an unfavorable risk/reward requiring UNDERWEIGHT/SELL positioning.
EV: Wait for clean break and hold below $328.48 (lower Bollinger band) — would confirm deeper correction toward $319 (February low). At $319, valuation becomes more reasonable and credit-cycle concerns get priced in, creating a real risk/reward setup. · concedes: AXP is genuinely a best-in-class operator with 34% ROE; Q2 2026 numbers are genuinely impressive: Revenue +10%, NII +11%, EPS +11%, Operating CF +23%; Higher-for-longer rates ARE true on the margin for NII growth (Q2 +11% YoY); Premium customer base is more insulated than mass-market from macro headwinds; 13% below 52-week high is meaningful reset — market already repricing AXP; Roughly 50/50 odds between bullish breakout and bearish breakdown from current technical setup
→ vs conservative: 200 SMA break of only $1.43 on sub-average volume is noise, not regime change; single-point breakdowns that get immediately faded are reliable reversal patterns
→ vs conservative: MACD cross at -0.09 is shallow and mechanical, not deep bearish deterioration; RSI at 44.84 is neutral, not confirming a real bottom
→ vs conservative: Waiting for close above 50 SMA at 340.14 with positive MACD histogram surrenders 5-7% of gains to confirmation bias
→ vs conservative: Credit cycle fear is overblown given 8% recession probability and historical-low delinquencies
→ vs neutral: 5-8% pullback to $300-320 may never materialize; 85% probability of no Fed cuts in 2026 means the dovish pivot being waited for is not coming
→ vs neutral: Waiting for deeper drawdown in a name with pristine Q2 print (+10% revenue, +11% NII, +11% EPS, +23% operating cash flow) surrenders thesis-intact gains
→ vs neutral: Higher-for-longer rates directly benefit AXP through net interest income expansion, not a headwind as assumed
| ATR(14) |
| 7.15 |
| neutral |
Support: 328.48 · 326.17 · 319.35 | Resistance: 340.14 · 341.24 · 348.99 · 352.9
AXP is in a choppy, range-bound phase with confirmed bearish bias. Price closed below all three moving averages including a first-time breakdown under the 200 SMA. MACD just crossed negative with expanding histogram, and RSI failed to hold a bounce from oversold conditions. The lower Bollinger Band at 328.48 represents critical near-term support; a close below would trigger band expansion and likely sharper downside. ATR of 7.15 indicates moderate contracting volatility that often precedes directional expansion. Recommended action is HOLD with tightened stops (~334.69 based on 2× ATR from swing high), avoiding new longs until price reclaims 50 SMA (340.14) with positive MACD histogram confirmation.
Market Cap
$227.05B
Beta
1.055
P/E (TTM)
20.41x
Forward P/E
16.71x
PEG Ratio
1.6
Price/Book
6.62x
Dividend Yield
1.11%
52-Week Range
$290.97 – $387.49
50-Day MA
$340.00 / $339.29
Book Value
$50.79
Net Income (TTM)
$11.31B
Revenue (TTM)
$70.91B
Profit Margin
16.14%
Operating Margin
20.32%
Return on Equity (ROE)
34.38%
Return on Assets (ROA)
3.79%
Current Ratio
1.55
Revenue 2021
$52.86B
Revenue 2022
$60.52B
Revenue 2023
$65.95B
Revenue 2024
$72.23B
Net Interest Income 2021
$9.90B
Net Interest Income 2022
$13.13B
Net Interest Income 2023
$15.54B
Net Interest Income 2024
$17.36B
Net Income 2021
$7.51B
Net Income 2022
$8.37B
Net Income 2023
$10.13B
Net Income 2024
$10.83B
Diluted EPS 2021
$9.85
Diluted EPS 2022
$11.21
Diluted EPS 2023
$14.01
Diluted EPS 2024
$15.38
Diluted Shares 2021
752M
Diluted Shares 2022
736M
Diluted Shares 2023
713M
Diluted Shares 2024
696M
Dividends Paid 2021
$1.57B
Dividends Paid 2022
$1.78B
Dividends Paid 2023
$2.00B
Dividends Paid 2024
$2.27B
Q2 2026 Revenue
$19.64B
Q2 2026 Net Interest Income
$4.65B
Q2 2026 Pretax Income
$4.07B
Q2 2026 Net Income
$3.11B
Q2 2026 Diluted EPS
$4.53
Q2 2026 Operating CF
$5.37B
Q2 2026 Free CF
$4.47B
Total Assets (Q2 2026)
$308.20B
Net Loans (Q2 2026)
$225.06B
Cash & Equivalents (Q2 2026)
$45.17B
Long-Term Debt (Q2 2026)
$57.02B
Total Debt (Q2 2026)
$59.05B
Stockholders Equity (Q2 2026)
$34.28B
Net Debt (Q2 2026)
$13.88B
Operating CF (TTM)
~$22.4B
Free CF (TTM)
~$15.0B
Share Buybacks (TTM)
~$7.5B
Dividends Paid (TTM)
~$2.4B
CapEx
~$3.4B
Forward EPS
$20.12
2024 Gain on Sale of Business
$531M
Q4 2025 Restructuring Charge
$96M
Q4 2024 Restructuring Charge
$123M
Strengths
Concerns
American Express is a high-quality franchise with best-in-class 34.38% ROE and accelerating earnings momentum (Q2 2026 EPS +11% to $4.53), driven by strong net interest income growth and aggressive buybacks compounding EPS. The company's premium brand and closed-loop payment network provide durable competitive advantages, with revenue CAGR of ~11% and EPS CAGR of ~16% over 2021-2024. However, the stock trades at 20.41x P/E and 6.62x P/B near 52-week highs, pricing in near-perfect execution with limited margin of safety; new entrants should consider scaling in on weakness to the $300-320 support zone rather than chasing elevated levels.
Macro: The macro backdrop is broadly neutral-to-mildly-negative for AXP. The 30-year Treasury yield touched a 19-year high this week as long-duration supply concerns and rising oil prices pressured the bond market, with the S&P 500, Dow, and Nasdaq all closing lower. The Fed is overwhelmingly priced as hawkish with an 85% probability of zero cuts in 2026 ($7.30M Polymarket volume), compared to 0% for 6 cuts or 9+ cuts. U.S. recession odds remain low at 8% (stable), supporting consumer spending, while Japan recession odds surged to 60% (+31.5pp week-over-week)—a non-factor for AXP given its ~90% U.S. revenue mix. Geopolitical risks include Trump's Oman threats and Libya pipeline developments, which pushed crude higher and contributed to the risk-off equity tape. No FRED macro series were available for direct verification; all quantitative reads are sourced from prediction markets.